Phakomatosis: Difference between revisions

From WikiMD's Wellness Encyclopedia

m 1 revision imported
 
CSV import
Line 64: Line 64:


{{nervoussystem-disease-stub}}
{{nervoussystem-disease-stub}}
<gallery>
File:Symptoms_of_neurofibromatosis_type_1_-_censored_version.png|Symptoms of Neurofibromatosis Type 1
File:Symptoms_of_neurofibromatosis_type_1.png|Symptoms of Neurofibromatosis Type 1
File:Diagnostic_criteria_of_neurofibromatosis_type_I.jpg|Diagnostic Criteria of Neurofibromatosis Type I
File:Neurofibromatosis_type_II_tumor_types.png|Neurofibromatosis Type II Tumor Types
File:Patient_with_facial_angiofibromas_caused_by_tuberous_sclerosis.jpg|Patient with Facial Angiofibromas Caused by Tuberous Sclerosis
File:Symptoms_and_signs_of_tuberous_sclerosis.png|Symptoms and Signs of Tuberous Sclerosis
File:Port_wine_stains_of_an_8-year-old_female_with_Sturge-Weber_Syndrome.png|Port Wine Stains of an 8-year-old Female with Sturge-Weber Syndrome
File:Cysts_and_tumors_in_Von_Hippel–Lindau_disease.png|Cysts and Tumors in Von Hippel–Lindau Disease
</gallery>

Revision as of 11:52, 18 February 2025

Phakomatoses
[[File:|250px|alt=|]]
Synonyms Phakomatosis
Pronounce
Field
Symptoms
Complications
Onset
Duration
Types
Causes
Risks
Diagnosis
Differential diagnosis
Prevention
Treatment
Medication
Prognosis
Frequency
Deaths


Phakomatoses refers to a group of neuro-oculo-cutaneous syndromes or neurocutaneous disorders involving structures arising from the embryonic ectoderm. These multisystem disorders involve the ectodermal structures like central nervous system, skin and eyes.<ref name="neuroderm 2014">,

 Neurodermatology., 
 Handbook of Clinical Neurology, 
 
 Vol. 121,
 pp. 1561–94,
 DOI: 10.1016/B978-0-7020-4088-7.00104-8,
 PMID: 24365436,</ref> The lesions have a variable severity.<ref name="Rook(FRCP.)2004">, 
  
 Rook's textbook of dermatology. online version, 
  
 Wiley-Blackwell, 
 2004, 
  
  
 ISBN 978-0-632-06429-8, 
  
  
  
 Pages: 5–,</ref><ref>, 
 Neurocutaneous disorders., 
 Dermatologic Clinics, 
 
 Vol. 20(Issue: 3),
 pp. 547–60, viii,
 DOI: 10.1016/s0733-8635(02)00005-0,
 PMID: 12170887,</ref> However, it has been subsequently noted that mesodermal and endodermal tissues too are involved.

A number of genetic and acquired diseases come in this category and may affect one or more of these tissues. However, in some conditions, such as von Hippel-Lindau disease, ectodermal presentation is minimal.<ref>

Phakomatosis(link). {{{website}}}. GE.



</ref>

Examples

Phakomatoses are inconsistently defined, and there is a lack of consensus about what conditions are included in this category.<ref name="YanoffDuker2009">,

 Ophthalmology. online version, 
  
 Elsevier Health Sciences, 
 2009, 
  
  
 ISBN 978-0-323-04332-8, 
  
  
  
 Pages: 937–,</ref>

Conditions included are:

Etymology

The term, from the Greek φακός, phakos, "spot, lens", suffix-(o)ma (-ωμα) and the suffix -osis, also called "Mother's spot" or "Birth mark" was introduced by Jan van der Hoeve in 1920, before the distinct genetic basis of each of these diseases was understood.<ref> Enersen, Ole Daniel. Jan van der Hoeve(link). {{{website}}}. Who Named It?.



</ref>

References

<references group="" responsive="1"></references>


External links

  • OMIM is an Online Catalog of Human Genes and Genetic Disorders



Stub icon
   This article is a  stub. You can help WikiMD by expanding it!